Paradigm Biopharmaceuticals Ltd.ASX: PAR

Successful Completion of $16M Placement for Phase 3

Dec 9, 2024 at 3:42 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment